The introduction of nicotinamide for a nicotine replacement in e-cigarette and smokeless products represents an important regulatory obstacle to the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is thought to act as a sedative at higher dosages6. The claims made by Nicotine